281 related articles for article (PubMed ID: 16435016)
61. Hematopoietic stem cell transplantation for primary lymphoid immunodeficiencies.
Kapoor N; Crooks G; Kohn DB; Parkman R
Semin Hematol; 1998 Oct; 35(4):346-53. PubMed ID: 9801263
[TBL] [Abstract][Full Text] [Related]
62. Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.
Ringdén O; Remberger M; Svenberg P; Svahn BM; Dahllöf G; Gustafsson B; Hassan Z; Omazic B; Uzunel M; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Bone Marrow Transplant; 2007 Apr; 39(7):383-8. PubMed ID: 17310137
[TBL] [Abstract][Full Text] [Related]
63. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group.
Locatelli F; Zecca M; Pession A; Morreale G; Longoni D; Di Bartolomeo P; Porta F; Fagioli F; Nobili B; Bernardo ME; Messina C;
Haematologica; 2007 Oct; 92(10):1381-8. PubMed ID: 18024375
[TBL] [Abstract][Full Text] [Related]
64. Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us.
Rappeport JM; O'Reilly RJ; Kapoor N; Parkman R
Immunol Allergy Clin North Am; 2010 Feb; 30(1):17-30. PubMed ID: 20113884
[TBL] [Abstract][Full Text] [Related]
65. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
[TBL] [Abstract][Full Text] [Related]
66. [Analysis of 66 cases received hematopoietic stem cell transplantation from unrelated donors].
Chen YH; Huang XJ; Chen H; Xu LP; Liu DH; Jiang Q; Zhang YC; Han W; Gao ZY; Wang JZ; Liu KY; Wu T; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):656-60. PubMed ID: 16620550
[TBL] [Abstract][Full Text] [Related]
67. Outcome of boost haemopoietic stem cell transplant for decreased donor chimerism or graft dysfunction in primary immunodeficiency.
Slatter MA; Bhattacharya A; Abinun M; Flood TJ; Cant AJ; Gennery AR
Bone Marrow Transplant; 2005 Apr; 35(7):683-9. PubMed ID: 15723084
[TBL] [Abstract][Full Text] [Related]
68. Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman-Diamond syndrome.
Fleitz J; Rumelhart S; Goldman F; Ambruso D; Sokol RJ; Pacini D; Quinones R; Holida M; Lee N; Tannous R; Giller R
Bone Marrow Transplant; 2002 Jan; 29(1):75-9. PubMed ID: 11840149
[TBL] [Abstract][Full Text] [Related]
69. Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.
Mugishima H; Ohga S; Ohara A; Kojima S; Fujisawa K; Tsukimoto I;
Pediatr Transplant; 2007 Sep; 11(6):601-7. PubMed ID: 17663681
[TBL] [Abstract][Full Text] [Related]
70. Searching for alternative hematopoietic stem cell donors for pediatric patients.
Rocha V; Locatelli F
Bone Marrow Transplant; 2008 Jan; 41(2):207-14. PubMed ID: 18084331
[TBL] [Abstract][Full Text] [Related]
71. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP).
Cesaro S; Locatelli F; Lanino E; Porta F; Di Maio L; Messina C; Prete A; Ripaldi M; Maximova N; Giorgiani G; Rondelli R; Aricò M; Fagioli F
Haematologica; 2008 Nov; 93(11):1694-701. PubMed ID: 18768529
[TBL] [Abstract][Full Text] [Related]
72. Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies.
Wang Y; Chen F; Han Y; Fu ZZ; Tang XW; Miao M; Qiu HY; Jin ZM; Sun AN; Wu DP
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1258-64. PubMed ID: 19747633
[TBL] [Abstract][Full Text] [Related]
73. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematologic malignancies in children.
Huang X; Liu D; Liu K; Xu L; Chen H; Han W; Chen Y; Wang Y; Zhang X
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):91-4. PubMed ID: 19147085
[TBL] [Abstract][Full Text] [Related]
74. Safety of hematopoietic stem cell transplantation in children less than three years of age.
Dvorak CC; Wright NB; Wong WB; Kristovich KM; Matthews EW; Weinberg KI; Amylon MD; Agarwal R
Pediatr Hematol Oncol; 2008 Dec; 25(8):705-22. PubMed ID: 19065437
[TBL] [Abstract][Full Text] [Related]
75. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
[TBL] [Abstract][Full Text] [Related]
76. [Treatment of acquired severe aplastic anemia in pediatric patients with immunosuppression and allogeneic stem cell hematopoietic transplant].
Barriga C F; Wietstruck P A; Becker K A; Zúñiga C P; Besa De C P; Alvarez Z M; Ocqueteau T M; Bertín C P
Rev Med Chil; 2007 Nov; 135(11):1421-8. PubMed ID: 18259653
[TBL] [Abstract][Full Text] [Related]
77. Impact of conditioning on outcome of hematopoietic stem cell transplantation for wiskott-Aldrich syndrome.
Stepensky P; Krauss A; Goldstein G; Zaidman I; Elhasid R; Bielorai B; Somech R; Or R; Stein J; Revel-Vilk S; Weintraub M
J Pediatr Hematol Oncol; 2013 Aug; 35(6):e234-8. PubMed ID: 23389496
[TBL] [Abstract][Full Text] [Related]
78. Impact of activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantation.
Giebel S; Nowak I; Wojnar J; Markiewicz M; Dziaczkowska J; Wylezol I; Krawczyk-Kulis M; Bloch R; Kusnierczyk P; Holowiecki J
Transplant Proc; 2006; 38(1):287-91. PubMed ID: 16504727
[TBL] [Abstract][Full Text] [Related]
79. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
[TBL] [Abstract][Full Text] [Related]
80. Hematopoietic Stem Cell Transplantations for Primary Immune Deficiencies: 3 Decades of Experience From a Tertiary Medical Center.
Rousso SZ; Shamriz O; Zilkha A; Braun J; Averbuch D; Or R; Weintraub M; Revel-Vilk S; Stepensky P
J Pediatr Hematol Oncol; 2015 Jul; 37(5):e295-300. PubMed ID: 25985240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
